Lovro Kramer

558 total citations
14 papers, 363 citations indexed

About

Lovro Kramer is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Lovro Kramer has authored 14 papers receiving a total of 363 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Lovro Kramer's work include Protease and Inhibitor Mechanisms (4 papers), RNA Interference and Gene Delivery (3 papers) and Cell Adhesion Molecules Research (3 papers). Lovro Kramer is often cited by papers focused on Protease and Inhibitor Mechanisms (4 papers), RNA Interference and Gene Delivery (3 papers) and Cell Adhesion Molecules Research (3 papers). Lovro Kramer collaborates with scholars based in Slovenia, Switzerland and United States. Lovro Kramer's co-authors include Boris Turk, Vito Türk, Mario Kurtjak, Danilo Suvorov, Marija Vukomanović, Olga Vasiljeva, Markus Rudin, Andraž Krajnc, Matej Vizovišek and K. Ulrich Wendt and has published in prestigious journals such as Angewandte Chemie International Edition, Trends in Pharmacological Sciences and Frontiers in Immunology.

In The Last Decade

Lovro Kramer

12 papers receiving 358 citations

Peers

Lovro Kramer
Lovro Kramer
Citations per year, relative to Lovro Kramer Lovro Kramer (= 1×) peers Zhao-Hui Jin

Countries citing papers authored by Lovro Kramer

Since Specialization
Citations

This map shows the geographic impact of Lovro Kramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lovro Kramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lovro Kramer more than expected).

Fields of papers citing papers by Lovro Kramer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lovro Kramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lovro Kramer. The network helps show where Lovro Kramer may publish in the future.

Co-authorship network of co-authors of Lovro Kramer

This figure shows the co-authorship network connecting the top 25 collaborators of Lovro Kramer. A scholar is included among the top collaborators of Lovro Kramer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lovro Kramer. Lovro Kramer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Marco, F. De, Alessandra Dal Molin, Lovro Kramer, et al.. (2025). A genome-scale CRISPR deletion screen in Chinese hamster ovary cells reveals essential regions of the coding and non-coding genome. Metabolic Engineering. 92. 194–207.
2.
Kramer, Lovro, et al.. (2024). Modulating antibody N-glycosylation through feed additives using a multi-tiered approach. Frontiers in Bioengineering and Biotechnology. 12. 1448925–1448925. 1 indexed citations
3.
Kramer, Lovro, et al.. (2023). The making of multivalent gamma delta TCR anti-CD3 bispecific T cell engagers. Frontiers in Immunology. 13. 1052090–1052090. 3 indexed citations
4.
Kramer, Lovro, et al.. (2022). Coupling CRISPR interference with FACS enrichment: New approach in glycoengineering of CHO cell lines for therapeutic glycoprotein production. Biotechnology Journal. 17(7). e2100499–e2100499. 2 indexed citations
5.
Scheper, Wouter, Tineke Aarts‐Riemens, Dennis X. Beringer, et al.. (2021). Characterization and modulation of anti-αβTCR antibodies and their respective binding sites at the βTCR chain to enrich engineered T cells. Molecular Therapy — Methods & Clinical Development. 22. 388–400. 5 indexed citations
6.
Kramer, Lovro, et al.. (2019). Stefin A-functionalized liposomes as a system for cathepsins S and L-targeted drug delivery. Biochimie. 166. 94–102. 17 indexed citations
7.
Kramer, Lovro, Vito Türk, & Boris Turk. (2017). The Future of Cysteine Cathepsins in Disease Management. Trends in Pharmacological Sciences. 38(10). 873–898. 149 indexed citations
8.
Kramer, Lovro, M. Renko, Vito Türk, et al.. (2017). Non-invasive in vivo imaging of tumour-associated cathepsin B by a highly selective inhibitory DARPin. Theranostics. 7(11). 2806–2821. 42 indexed citations
9.
Kurtjak, Mario, Marija Vukomanović, Lovro Kramer, & Danilo Suvorov. (2016). Biocompatible nano-gallium/hydroxyapatite nanocomposite with antimicrobial activity. Journal of Materials Science Materials in Medicine. 27(11). 170–170. 48 indexed citations
10.
Kurtjak, Mario, Marija Vukomanović, Andraž Krajnc, et al.. (2016). Designing Ga(iii)-containing hydroxyapatite with antibacterial activity. RSC Advances. 6(114). 112839–112852. 34 indexed citations
11.
Hu, Hai‐Yu, Divya Vats, Matej Vizovišek, et al.. (2014). In Vivo Imaging of Mouse Tumors by a Lipidated Cathepsin S Substrate. Angewandte Chemie International Edition. 53(29). 7669–7673. 54 indexed citations
12.
Hu, Hai‐Yu, Divya Vats, Matej Vizovišek, et al.. (2014). Visualisierung von Maustumoren mit einem lipidierten Cathepsin‐S‐Substrat. Angewandte Chemie. 126(29). 7802–7806. 5 indexed citations
13.
Jacobson, Elliott R., et al.. (1986). Renal neoplasia of snakes. Journal of the American Veterinary Medical Association. 189(9). 1134–1136. 2 indexed citations
14.
Centerwall, Willard R., et al.. (1983). Chromosome identification of the rusty-spotted cat (Felis rubiginosa): One more down and four to go. American Journal of Veterinary Research. 44(5). 856–858. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026